USPTO Examiner ULSH DUNG T - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18935754PROTECTIVE DEVICE FOR A SYRINGE NEEDLE TUBENovember 2024February 2025Allow400NoNo
18839828CLOSED TYPE MEDICINE LIQUID TRANSFER DEVICE AND SYSTEM WITH DOUBLE-CHAMBER INTERNAL CIRCULATIONAugust 2024January 2025Allow500NoNo
18594758ENHANCED PEN-LIKE PORTABLE DEVICE FOR CLEANING NEEDLE-FREE IV-CONNECTORSMarch 2024December 2024Allow920NoNo
18590727ATTACHMENT MECHANISM, MODULE AND ASSEMBLY HEREWITHFebruary 2024June 2024Allow400NoNo
18427210Universal Dosage Verification System and Method for Medical SyringeJanuary 2024June 2025Allow1630NoNo
18421659ELECTRONIC ADD-ON MODULE AND ASSEMBLY OF AN ELECTRONIC ADD-ON MODULE AND A DRUG DELIVERY DEVICEJanuary 2024July 2024Allow510NoNo
18504937SYSTEM AND METHOD FOR MONITORING FLUID DEFICITNovember 2023May 2025Allow1800NoNo
18449981Injection DeviceAugust 2023October 2024Allow1420NoNo
18226688ENHANCED PEN-LIKE PORTABLE DEVICE FOR CLEANING NEEDLE-FREE IV-CONNECTORSJuly 2023November 2023Allow400YesNo
18224381OPHTHALMIC DEVICEJuly 2023February 2024Allow700NoNo
18346693AUTO INJECTOR WITH CHARGER SAFETYJuly 2023February 2025Allow2010NoNo
18211971METHOD AND DEVICE FOR DELIVERING SUBCUTANEOUS DOSE THROUGH MULTIPLE INJECTIONSJune 2023April 2024Allow1010YesNo
18210879Devices and Methods for Fluid Transfer Through a Placed Peripheral Intravenous CatheterJune 2023July 2024Allow1310YesNo
18324087IRRIGATION AND ASPIRATION DEVICE AND METHODMay 2023September 2023Allow400YesNo
18199059FEEDING TUBE WITH ELECTROMAGNETIC SENSOR AND CAMERAMay 2023March 2024Abandon1010NoNo
18309542DATA COLLECTION DEVICEApril 2023June 2024Allow1410NoNo
18307719RFID DOSE TRACKING MECHANISM FOR INJECTION DEVICESApril 2023February 2025Allow2110NoNo
18305766AUTOINJECTORApril 2023October 2024Allow1820NoNo
18121122Simultaneous Control of Power and Irrigation During AblationMarch 2023July 2023Allow400YesNo
18116727CATHETER ASSEMBLYMarch 2023October 2023Allow810YesNo
18170394METHOD AND DEVICE FOR CAPTURING A DOSE DIALING EVENTFebruary 2023March 2024Allow1310NoNo
18160165Bone Marrow Aspiration Device And MethodJanuary 2023October 2023Allow900YesNo
18156898APPLICATION DEVICE FOR A FLUID DELIVERY APPARATUS AND METHOD OF USEJanuary 2023September 2023Allow810NoNo
18099112FEEDING TUBE WITH ELECTROMAGNETIC SENSORJanuary 2023May 2023Allow400YesNo
18150064PROCEDURE-BASED PROGRAMMING FOR INFUSION PUMPSJanuary 2023January 2024Allow1210NoNo
18069909DRUG INJECTION DEVICEDecember 2022November 2023Allow1100NoNo
18067263COVER FOR LIQUID DELIVERY SYSTEM WITH INTEGRATED PLUNGER POSITION SENSING USING FOCUSED OPTICAL BEAM AND LINEAR POTENTIOMETERDecember 2022July 2023Allow710YesNo
18082174APPARATUS AND METHOD FOR DETECTING LIQUID LEVEL IN A CLEAR OR PARTIALLY CLEAR CONTAINERDecember 2022April 2023Allow400YesNo
18065159DOSE DETECTION MODULE FOR A MEDICATION DELIVERY DEVICEDecember 2022October 2023Allow1110NoNo
18077642DETERMINING A STATUS OF AN INJECTIONDecember 2022November 2023Allow1110NoNo
18055658METHOD AND DEVICE FOR DELIVERING SUBCUTANEOUS DOSE THROUGH MULTIPLE INJECTIONSNovember 2022March 2023Allow400YesNo
17971756Simultaneous Control of Power and Irrigation During AblationOctober 2022February 2023Allow300NoNo
17947887SYRINGE SYSTEMSeptember 2022August 2023Allow1110NoNo
17948100UNIDIRECTIONAL CATHETER CONTROL HANDLE WITH TENSIONING CONTROLSeptember 2022April 2023Allow710NoNo
17943134APPARATUS AND METHOD FOR TRANS-ROUND WINDOW MEMBRANE DRUG DELIVERYSeptember 2022January 2023Allow400YesNo
17942100Medical Line Tension Mitigation Securement DeviceSeptember 2022June 2024Allow2140YesNo
17910123NEEDLE SHIELDING DEVICESeptember 2022June 2025Allow3300YesNo
17894305Breast Pumping SystemAugust 2022July 2025Allow3400YesNo
17801975STOPCOCK APPARATUS FOR ANGIOGRAPHY INJECTOR FLUID PATHSAugust 2022June 2025Allow3400YesNo
17817415JOINT DISLOCATION REDUCTION DEVICE AND METHOD USING THE SAMEAugust 2022June 2025Allow3500YesNo
17815879DRUG DELIVERY METHODS AND SYSTEMSJuly 2022January 2024Allow1820NoNo
17815896Delivery AdapterJuly 2022May 2024Allow2230YesNo
17767747GASTROJEJUNAL TUBE APPARATUS AND METHODS OF USEJuly 2022May 2025Allow3700YesNo
17795624DRUG INJECTION CONTROL DEVICE HAVING STRUCTURE IN WHICH ROD LOCK SCREW-COUPLED TO PISTON ROD CAN MAKE LINEAR MOTION UNDER RESTRICTED ROTATION WITHIN ROD HOLDERJuly 2022June 2025Allow3400NoNo
17795711DRUG INJECTION CONTROL DEVICE FOR TEMPORARILY MAINTAINING TWIST OF TORSION SPRING TO WHICH ROTATIONAL FORCE IS APPLIED THROUGH DOSE DIALJuly 2022May 2025Allow3400NoNo
17873977Flow Sensor for VentilationJuly 2022February 2024Allow1920NoNo
17843207INJECTION DEVICE FOR INJECTING A PHARMACEUTICAL SUBSTANCE, AND INJECTION LOADING PART FOR SUCH AN INJECTION DEVICEJune 2022May 2025Allow3500YesNo
17842237BLOOD COLLECTION DEVICES, SYSTEMS, AND METHODSJune 2022December 2022Allow610YesNo
17841956BLOOD COLLECTION DEVICES, SYSTEMS, AND METHODSJune 2022August 2022Allow200YesNo
17781906Dosing Mechanism with Rotational End Stop Mechanism for Terminating Dose DispenseJune 2022May 2025Allow3600NoNo
17828618MEDICAMENT DELIVERY DEVICEMay 2022September 2024Allow2730YesNo
17829161AUTO INJECTOR WITH CHARGER SAFETYMay 2022April 2023Allow1010NoNo
17777216PISTON ROD DRIVE MECHANISMMay 2022May 2025Allow3600NoNo
17743357PRESSURE SPIKE ABSORBING SYSTEMSMay 2022January 2024Allow2130YesNo
17662854DRUG INJECTION DEVICEMay 2022February 2023Allow900NoNo
17773137Injection Device for Delivering a Liquid Drug and a Method of AssemblyApril 2022April 2025Allow3500NoNo
17773198CAP FOR PRE-FILLED SYRINGE WITH LUER-LOCK CONNECTORApril 2022June 2025Allow3700YesNo
17728165Supplemental Device for Attachment to an Injection DeviceApril 2022June 2023Allow1320YesNo
17660536METHOD AND APPARATUS FOR TIGHTENING SKIN AND OTHER TISSUESApril 2022September 2023Allow1620NoNo
17660071SYSTEM AND METHOD FOR THE EFFECTIVE, RELIABLE AND FOOLPROOF DELIVERY OF EMBOLIC AGENTSApril 2022August 2024Allow2840NoYes
17769859Injection DeviceApril 2022July 2024Allow2721NoNo
17716558Devices and Methods for Fluid Transfer Through a Placed Peripheral Intravenous CatheterApril 2022April 2023Allow1310NoNo
17699357Breast Pumping SystemMarch 2022March 2025Allow3600YesNo
17679979System and Method for Breast Pump Flange SizingFebruary 2022April 2025Allow3700NoNo
17676964BLOOD COLLECTION DEVICES, SYSTEMS, AND METHODSFebruary 2022June 2022Allow400YesNo
17590433SYRINGE PUMP MODULEFebruary 2022November 2023Allow2110NoNo
17553142ASSEMBLY FOR A MEDICAMENT DELIVERY DEVICEDecember 2021June 2025Allow4200YesNo
17520899Injection Configuration with Modified Luer Connector for Reduced Dead SpaceNovember 2021April 2024Allow2920NoNo
17520053METHODS FOR MAKING AND USING PHARMACEUTICAL COMPOSITIONS FOR IONTOPHORESISNovember 2021February 2025Allow4000NoNo
17453420INTRAVENOUS TUBING VENTING ASSEMBLYNovember 2021September 2023Allow2310NoNo
17498602INJECTION DELIVERY DEVICEOctober 2021July 2024Allow3411NoNo
17488875Needle Safety Guard For Tattoo Needle DeviceSeptember 2021March 2023Allow1810NoNo
17476987CATHETER ASSEMBLYSeptember 2021December 2022Allow1520YesNo
17472378VASCULAR ACCESS SYSTEMS AND METHODSSeptember 2021June 2023Allow2100NoNo
17472550DRUG DELIVERY DEVICESeptember 2021August 2023Allow2400NoNo
17472554KEYED CONNECTORSSeptember 2021October 2024Allow3700NoNo
17472546DRUG DELIVERY DEVICESeptember 2021October 2023Abandon2510NoNo
17433165Steerable and flexible robotic endoscopic tools for minimally invasive proceduresAugust 2021March 2025Allow4301NoNo
17409215DYNAMIC WALLED TUBINGAugust 2021November 2023Allow2720NoNo
17404266INDWELLING DEVICE FOR TREATING FLORA AND METHOD FOR TREATING FLORAAugust 2021June 2025Allow4601YesNo
17392741METHODS AND APPARATUS TO IMPROVE BREAST MILK PRODUCTIONAugust 2021May 2023Abandon2210NoNo
17378023Devices and Methods for Fluid Transfer Through a Placed Peripheral Intravenous CatheterJuly 2021October 2022Allow1500NoNo
17420618ORAL DRUG DELIVERY DEVICEJuly 2021August 2024Allow3810YesNo
17420275ACCESSORY DEVICE FOR DRUG DELIVERY DEVICEJuly 2021March 2024Allow3200NoNo
17361546Medicament Delivery DeviceJune 2021December 2022Allow1800YesNo
17355555REUSABLE INJECTION PENSJune 2021March 2023Allow2000NoNo
17353449ACCESSORY DEVICES, SYSTEMS, AND METHODS FOR MEDICINE ADMINISTRATION AND TRACKINGJune 2021March 2025Allow4520YesNo
17351709Bone Marrow Aspiration Device And MethodJune 2021October 2022Allow1600YesNo
17351910FEEDING ACCESSORY AND FEEDING ASSEMBLYJune 2021August 2023Abandon2610NoNo
17346690SYRINGE CAPPING AND UNCAPPING DEVICEJune 2021May 2023Allow2310YesNo
17340246PARENTERAL INJECTION APPARATUSJune 2021May 2023Allow2300YesNo
17297959Assembly for a Drug Delivery Device, Drug Delivery Device and Method for Producing a Drug Delivery DeviceMay 2021June 2025Allow4910NoNo
17328951INJECTION DEVICESMay 2021May 2023Abandon2410NoNo
17327683Cartridge Devices for Administration of a MedicamentMay 2021April 2025Allow4610NoNo
17319742Intravitreal Injection Device With Combined Vitreous SamplingMay 2021June 2023Allow2510YesNo
17292952DRUG DELIVERY ASSEMBLY WITH MOVING SENSOR SYSTEMMay 2021November 2024Allow4210NoNo
17315187CATHETERIZATION METHOD AND APPARATUSMay 2021January 2025Allow4411NoNo
17291306DRUG DELIVERY ASSEMBLY WITH SENSOR SAMPLING FEATUREMay 2021October 2024Allow4220NoNo
17244168Simultaneous Control of Power and Irrigation During AblationApril 2021October 2022Allow1700NoNo
17236776Insufflation Device with Heating Element, Humidifying Medium, and Device for Determining the Moisture ContentApril 2021April 2023Allow2310YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ULSH, DUNG T.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
1
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
19.2%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
8
Allowed After Appeal Filing
2
(25.0%)
Not Allowed After Appeal Filing
6
(75.0%)
Filing Benefit Percentile
33.4%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 25.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner ULSH, DUNG T - Prosecution Strategy Guide

Executive Summary

Examiner ULSH, DUNG T works in Art Unit 3783 and has examined 390 patent applications in our dataset. With an allowance rate of 82.3%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 34 months.

Allowance Patterns

Examiner ULSH, DUNG T's allowance rate of 82.3% places them in the 48% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by ULSH, DUNG T receive 1.53 office actions before reaching final disposition. This places the examiner in the 38% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by ULSH, DUNG T is 34 months. This places the examiner in the 25% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +13.6% benefit to allowance rate for applications examined by ULSH, DUNG T. This interview benefit is in the 55% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 32.0% of applications are subsequently allowed. This success rate is in the 59% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 39.8% of cases where such amendments are filed. This entry rate is in the 53% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 133.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 86% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 83.3% of appeals filed. This is in the 75% percentile among all examiners. Of these withdrawals, 40.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 40.7% are granted (fully or in part). This grant rate is in the 41% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 43% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 42% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.